Darcie Sandschafer

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Clinical Practice

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Future oncology (London, England)

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) (2024)
Heather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Jennifer R Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E Shaw, Michael A Pulsipher, John P Miller, Steven M Devine
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim. Blood advances 8 (15) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Heather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Jennifer R Schenfeld, Darcie Sandschafer, Linda J Burns, Bronwen E Shaw, Michael A Pulsipher, John P Miller, Steven M Devine
Long-term Outcomes of Peripheral Blood Stem Cell Unrelated Donors Mobilized with Filgrastim. Blood advances (2024)
Ran Jin, Adesuwa S Ogbomo, Neil A Accortt, Lincy S Lal, Geetanjali Bishi, Darcie Sandschafer, Jerome H Goldschmidt
Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb). Therapeutic advances in medical oncology 15 (2023)
Ran Jin, Adesuwa S Ogbomo, Neil A Accortt, Lincy S Lal, Geetanjali Bishi, Darcie Sandschafer, Jerome H Goldschmidt
Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb). Therapeutic advances in medical oncology 15 (2023)